As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
[google_news title=”” keyword=”breast cancer diagnosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Breast cancer diagnosis
- Pinkie the breast cancer caravan to visit Southland, offering free health adviceon February 7, 2023 at 3:41 pm
Around 240 women are diagnosed with breast cancer in the Southern region every year, so two nurses in a pink caravan will be in Southland to answer any questions.
- Girl, 7, becomes youngest person in the world to be diagnosed with breast canceron February 7, 2023 at 2:31 pm
The mother of the youngster, from Chile, first found a lump on her daughter's breast when she was five and she has now undergone an operation to remove the affected area ...
- After 30 years of research, pill developed at Duke for breast cancer approved for useon February 7, 2023 at 10:07 am
People ask ‘why do you want to work in drug development?’,” a researcher said. “I want to put something in a bottle and last Friday, I saw the picture of the drug in the bottle.” ...
- How to Be a Friend to a Person With Breast Canceron February 7, 2023 at 9:13 am
Just know I am here for you and am thinking of you’ can go a long way.” Here are seven ways you can be supportive to someone who’s living with breast cancer. Go with your friend to chemo sessions and ...
- Physical Function May Decline in Women After Cancer Diagnosis, Throughout Survivorshipon February 7, 2023 at 8:00 am
Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead ...
- Mum shares surprising symptom after her little girl, 7, is one of youngest ever to be diagnosed with breast canceron February 7, 2023 at 6:19 am
A MUM has revealed how she discovered her little girl had breast cancer, being one of the youngest ever children to develop the condition. The youngster, now 7, started showing signs when she was ...
- First she fought breast cancer. Then she learned her chemo drug put her at risk for heart disease.on February 7, 2023 at 1:35 am
Almost five years after her cancer diagnosis, Tara Daudani learned one of her chemo drugs put her at risk of heart disease.
- Breast cancer awareness: A guide on prevention, detection and diagnosison February 6, 2023 at 4:30 pm
Breast cancer is now paving its way to being the number one cancer in women in India. That’s why we need to make sure that awareness about prevention, early detection and the treatment options are ...
- Daughter’s diagnosis leads to mother’s breast cancer discoveryon February 2, 2023 at 9:51 am
After a deeper investigation, doctors determined it was breast cancer. Miller’s doctor, Novant Health’s Medical Director of Surgical Oncology Dr. Peter Turk, says Jaci was diagnosed with a cancer ...
via Bing News